Used as an intermediate in the synthesis of fluoroquinolone antibiotics, this compound plays a key role in pharmaceutical development due to the presence of the trifluoromethyl group, which enhances metabolic stability and bioavailability. Its structure supports the formation of core quinolone scaffolds important for antimicrobial activity. It is primarily employed in research settings for developing new agents against bacterial infections, especially those involving resistant strains. Additionally, it serves as a building block in medicinal chemistry for optimizing drug candidates targeting DNA gyrase and topoisomerase IV.